Dexpanthenol

Identification

Summary

Dexpanthenol is an alcoholic analogue of D-pantothenic acid that is used as a supplement or application to support a healthy epithelium and is also used to prevent vitamin deficiency in patients receiving total parenteral nutrition (TPN).

Brand Names

Fortaplex, Infuvite, Infuvite Pediatric, Mvi Pediatric, Neo-bex

Generic Name

Dexpanthenol

DrugBank Accession Number

DB09357

Background

Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium².

Due to its good penetration and high local concentrations, dexpanthanol is used in many topical products, such as ointments and lotions for treatment of dermatological conditions to relieve itching or promote healing. Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties ³.

Dexpanthenol is also available as a racemic mixture containing both the dextrorotatory form (dexpanthenol) and the levorotatory form (levopanthenol) as Panthenol. While pantothenic acid is optically active, only the dextrorotatory form (dexpanthenol) is biologically active.

Type

Small Molecule

Groups

Approved

Structure

Similar Structures

Weight: Average: 205.2515
Monoisotopic: 205.131408101
Chemical Formula: C₉H₁₉NO₄

Synonyms

(+)-Panthenol
(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide
Bepanthen
Bepanthene
Bepantol
D-panthenol
D-panthenol 50
D-Pantothenol
D-Pantothenyl alcohol
D(+)-Panthenol
Dexpantenol
Dexpanthenol
Dexpanthenolum
Pantol
Pantothenyl alcohol
Provitamin B

External IDs

201-327-3
BAY 81-2996
NSC-302962

Pharmacology

Indication

Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus.

Topical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy).

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Associated Conditions

Associated Therapies

Contraindications & Blackbox Warnings

Avoid life-threatening adverse drug events

Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events & improve clinical decision support.

Learn more

Pharmacodynamics

Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus.

Mechanism of action

Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties ³.

Absorption

Dexpanthenol is soluble in water and alcohol, although insoluble in fats and oil based substances. With the appropriate vehicle, Dexpanthenol is easily penetrated into the skin. Rate of penetration and absorption is reduced when Dexpanthenol is administered as an oil/water formula.

Volume of distribution

Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A. Highest concentrations are found in the liver, adrenal glands, heart, and kidneys.

Protein binding

Plasma protein binding have not been reported.

Metabolism

Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.

Hover over products below to view reaction partners

Dexpanthenol
- Pantothenic acid

Route of elimination

Milk of nursing mothers receiving a normal diet contains about 2 ug of pantothenic acid per mL. About 70% of an oral dose of pantothenic acid is excreted unchanged in urine and about 30% in feces.

Half-life

Half life have not been reported

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

Learn more

Improve decision support & research outcomes with our structured adverse effects data.

Learn more

Toxicity

Mouse LD50 : 9gm/kg (Intraperitoneal) Mouse: LD50 7gm/kg (Intravenous) Mouse: LD50 15gm/kg (Oral) Rabbit LD50 4gm/kg (Oral)

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Drug	Interaction
Integrate drug-drug interactions in your software
Abacavir	Abacavir may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Aceclofenac	Aceclofenac may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Acemetacin	Acemetacin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Acetaminophen	Acetaminophen may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Acetazolamide	Acetazolamide may increase the excretion rate of Dexpanthenol which could result in a lower serum level and potentially a reduction in efficacy.
Acetyldigitoxin	The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Dexpanthenol is combined with Acetyldigitoxin.
Acetylsalicylic acid	Acetylsalicylic acid may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Aclidinium	Aclidinium may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Acrivastine	Dexpanthenol may decrease the excretion rate of Acrivastine which could result in a higher serum level.
Acyclovir	Acyclovir may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Food Interactions

No interactions found.

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Active Moieties

Name	Kind	UNII	CAS	InChI Key
Pantothenic acid	unknown	19F5HK2737	79-83-4	GHOKWGTUZJEAQD-ZETCQYMHSA-N

International/Other Brands

Cozyme / Ilopan / Motilyn / Panadon / Panthoderm / Synapan / Thenalton / Zentinic

Brand Name Prescription Products

Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End	Region	Image
Dexpanthenol	Injection, solution	250 mg/1mL	Intramuscular; Intravenous	American Regent	1993-08-20	2016-11-09

Over the Counter Products

Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End
Babysons	Ointment	50 mg/1g	Topical	Laboratorios Quimica Son's, S.A. de C.V	2020-06-15	Not applicable
BEPANTHEN	Ointment	5 mg	Cutaneous	Bayer De Mexico, s.a. De c.v.	2015-11-24	Not applicable
BEPANTHEN OINTMENT	Ointment		Topical	BAYER CO. (MALAYSIA) SDN. BHD.	2020-09-08	Not applicable
Eros Aqua Sensations and Care Woman	Gel	0.5 g/100mL	Topical	MEGASOL COSMETIC GMBH	2012-10-01	2018-01-17
MAR PLUS 5% NASAL SPRAY	Solution; Spray	50 mg/1mL	Nasal	บริษัท สตาดา (ประเทศไทย) จำกัด	2014-08-21	Not applicable
Perfect Pore Clean I	Liquid	0.001 g/1mL	Topical	Ami Cosmetic Co.,Ltd.	2014-04-14	2019-01-15
Vitalizer White	Liquid	0.0005 g/1mL	Topical	Ami Cosmetic Co.,Ltd.	2014-04-14	2019-01-15
Yozum Well Being Hair Color	Liquid	0.2 g/100g	Topical	Yozum Korea	2014-12-08	Not applicable

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Adult Infuvite Multiple Vitamins	Dexpanthenol (15 mg/10mL) + Ascorbic acid (200 mg/10mL) + Biotin (60 ug/10mL) + Cholecalciferol (200 [iU]/10mL) + Cyanocobalamin (5 ug/10mL) + Riboflavin-5'-phosphate sodium salt dihydrate (3.6 mg/10mL) + Folic acid (600 ug/10mL) + Nicotinamide (40 mg/10mL) + Phylloquinone (150 ug/10mL) + Pyridoxine hydrochloride (6 mg/10mL) + Thiamine hydrochloride (6 mg/10mL) + Vitamin A palmitate (3300 [iU]/10mL) + alpha-Tocopherol acetate (10 [iU]/10mL)	Injection, solution	Intravenous	Sandoz Inc	2005-05-18	Not applicable
Adult Infuvite Multiple Vitamins	Dexpanthenol (15 mg/10mL) + Ascorbic acid (200 mg/10mL) + Biotin (60 ug/10mL) + Cholecalciferol (200 [iU]/10mL) + Cyanocobalamin (5 ug/10mL) + Riboflavin-5'-phosphate sodium salt dihydrate (3.6 mg/10mL) + Folic acid (600 ug/10mL) + Nicotinamide (40 mg/10mL) + Phylloquinone (150 ug/10mL) + Pyridoxine hydrochloride (6 mg/10mL) + Thiamine hydrochloride (6 mg/10mL) + Vitamin A palmitate (3300 [iU]/10mL) + alpha-Tocopherol acetate (10 [iU]/10mL)	Injection, solution	Intravenous	Sandoz Inc	2003-06-16	Not applicable
Adult Infuvite Multiple Vitamins	Dexpanthenol (15 mg/10mL) + Ascorbic acid (200 mg/10mL) + Biotin (60 ug/10mL) + Cholecalciferol (200 [iU]/10mL) + Cyanocobalamin (5 ug/10mL) + Riboflavin-5'-phosphate sodium salt dihydrate (3.6 mg/10mL) + Folic acid (600 ug/10mL) + Nicotinamide (40 mg/10mL) + Phylloquinone (150 ug/10mL) + Pyridoxine hydrochloride (6 mg/10mL) + Thiamine hydrochloride (6 mg/10mL) + Vitamin A palmitate (3300 [iU]/10mL) + alpha-Tocopherol acetate (10 [iU]/10mL)	Injection, solution	Intravenous	Sandoz Inc	2003-06-16	Not applicable
Adult Infuvite Multiple Vitamins	Dexpanthenol (15 mg/10mL) + Ascorbic acid (200 mg/10mL) + Biotin (60 ug/10mL) + Cholecalciferol (200 [iU]/10mL) + Cyanocobalamin (5 ug/10mL) + Riboflavin-5'-phosphate sodium salt dihydrate (3.6 mg/10mL) + Folic acid (600 ug/10mL) + Nicotinamide (40 mg/10mL) + Phylloquinone (150 ug/10mL) + Pyridoxine hydrochloride (6 mg/10mL) + Thiamine hydrochloride (6 mg/10mL) + Vitamin A palmitate (3300 [iU]/10mL) + alpha-Tocopherol acetate (10 [iU]/10mL)	Injection, solution	Intravenous	Sandoz Inc	2005-05-18	Not applicable
Alsimine W Vitamins A D	Dexpanthenol (5 mg / amp) + Dexpanthenol (400 unit / amp) + Calcium glycerophosphate (13 mg / amp) + Cyanocobalamin (10 mcg / amp) + Ferrous gluconate (16 mg / amp) + Riboflavin-5'-phosphate sodium salt dihydrate (2 mg / amp) + Nicotinamide (40 mg / amp) + Pyridoxine hydrochloride (3 mg / amp) + Thiamine hydrochloride (4.5 mg / amp) + Vitamin A (10000 unit / amp)	Capsule; Liquid	Oral	Alsi Cie Ltee	1978-12-31	2003-05-21
Alsimine W Vitamins A D	Dexpanthenol (5 mg / amp) + Dexpanthenol (400 unit / amp) + Calcium glycerophosphate (13 mg / amp) + Cyanocobalamin (10 mcg / amp) + Ferrous gluconate (16 mg / amp) + Riboflavin-5'-phosphate sodium salt dihydrate (2 mg / amp) + Nicotinamide (40 mg / amp) + Pyridoxine hydrochloride (3 mg / amp) + Thiamine hydrochloride (4.5 mg / amp) + Vitamin A (10000 unit / amp)	Capsule; Liquid	Oral	Alsi Cie Ltee	1978-12-31	2003-05-21
Aquasol A Cream	Dexpanthenol (21.4 mg / g) + Vitamin A palmitate (7055 unit / g)	Cream	Topical	Rhone Poulenc Rorer	1993-12-31	1998-08-12
Atomy Herbal Hair Tonic	Dexpanthenol (0.4 mL/200mL) + Levomenthol (0.6 mL/200mL) + Salicylic acid (0.5 mL/200mL)	Liquid	Topical	Atomy Co., Ltd.	2010-04-29	Not applicable
AVETAL-12	Dexpanthenol (14.040 mg) + Ascorbic acid (100.000 mg) + Biotin (0.060 mg) + Cholecalciferol (0.005 mg) + Cyanocobalamin (0.005 mg) + Folic acid (0.400 mg) + Nicotinamide (40.000 mg) + Pyridoxine hydrochloride (4.862 mg) + Riboflavin (4.580 mg) + Thiamine hydrochloride (3.360 mg) + Vitamin A palmitate (1.914 mg) + alpha-Tocopherol acetate (10.000 mg)	Solution	Intravenous	Pharmaservice, s.a De c.v.	2022-08-22	Not applicable
B Complex W C and B12 Inj	Dexpanthenol (60 mg / 10 mL) + Ascorbic acid (500 mg / 10 mL) + Cyanocobalamin (10 mg / 10 mL) + Riboflavin-5'-phosphate sodium salt dihydrate (50 mg / 10 mL) + Nicotinamide (1.25 g / 10 mL) + Pyridoxine hydrochloride (50 mg / 10 mL) + Thiamine hydrochloride (500 mg / 10 mL)	Liquid	Intramuscular; Intravenous	E L Stickley And Co Ltd.	1963-12-31	1996-09-09

Unapproved/Other Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Atomy Herbal Hair Tonic	Dexpanthenol (0.4 mL/200mL) + Levomenthol (0.6 mL/200mL) + Salicylic acid (0.5 mL/200mL)	Liquid	Topical	Atomy Co., Ltd.	2010-04-29	Not applicable
B-Combo	Dexpanthenol (1 mg/1mL) + Mecobalamin (1 mg/1mL) + Nicotinamide (1 mg/1mL) + Pyridoxine (1 mg/1mL) + Riboflavin (1 mg/1mL) + Thiamine chloride (1 mg/1mL)	Injection	Intramuscular	Perdido Key Health And Wellness Inc	2015-11-23	Not applicable
B-plex 100	Dexpanthenol (2 mg/1mL) + Riboflavin-5'-phosphate sodium salt dihydrate (2 mg/1mL) + Nicotinamide (100 mg/1mL) + Pyridoxine hydrochloride (2 mg/1mL) + Thiamine hydrochloride (100 mg/1mL)	Injection, solution	Intramuscular; Intravenous	Merit Pharmaceutical	2012-01-01	Not applicable
BEHEPTAL 2 ML AMPUL, 5 ADET	Dexpanthenol (500 mg)	Solution		OSEL İLAÇ SAN. VE TİC. A.Ş.	2020-08-14	Not applicable
Black Repair Hair Boosting Tonic	Dexpanthenol (0.2 g/100mL) + Menthol (0.3 g/100mL) + Salicylic acid (0.25 g/100mL)	Liquid	Topical	DERMA CENTRIC INC	2021-03-28	Not applicable
Ch6 Greenol Herb Aloforthya Deep Forest	Dexpanthenol (0.2 g/100mL) + Nicotinamide (0.1 g/100mL) + Salicylic acid (0.2 g/100mL)	Shampoo	Topical	Rea Company	2022-10-01	Not applicable
Ch6 Greenol Herb Aloforthya Greentea Wood	Dexpanthenol (0.2 g/100mL) + Nicotinamide (0.1 g/100mL) + Salicylic acid (0.2 g/100mL)	Shampoo	Topical	Rea Company	2022-10-01	Not applicable
Ch6 Greenol Herb Aloforthya White Citrus	Dexpanthenol (0.2 g/100mL) + Nicotinamide (0.1 g/100mL) + Salicylic acid (0.2 g/100mL)	Shampoo	Topical	Rea Company	2022-10-01	Not applicable
Ch6 Greenol Herb Hair Control Non Wash Treatment	Dexpanthenol (0.2 g/100mL) + Levomenthol (0.3 g/100mL) + Salicylic acid (0.25 g/100mL)	Liquid	Topical	Rea Company	2022-10-01	Not applicable
CH6 Perfumed Aloforthya Aromatic herb	Dexpanthenol (0.2 g/100mL) + Nicotinamide (0.1 g/100mL) + Salicylic acid (0.2 g/100mL)	Shampoo	Topical	Rea Company	2022-09-01	Not applicable

Chemical Identifiers

UNII: 1O6C93RI7Z
CAS number: 81-13-0
InChI Key: SNPLKNRPJHDVJA-ZETCQYMHSA-N
InChI: InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1
IUPAC Name: (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide
SMILES: CC(C)(CO)[C@@H](O)C(=O)NCCCO

References

General References

Slyshenkov VS, Dymkowska D, Wojtczak L: Pantothenic acid and pantothenol increase biosynthesis of glutathione by boosting cell energetics. FEBS Lett. 2004 Jul 2;569(1-3):169-72. [Article]
Proksch E, de Bony R, Trapp S, Boudon S: Topical use of dexpanthenol: a 70th anniversary article. J Dermatolog Treat. 2017 Dec;28(8):766-773. doi: 10.1080/09546634.2017.1325310. Epub 2017 May 14. [Article]
Biro K, Thaci D, Ochsendorf FR, Kaufmann R, Boehncke WH: Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study. Contact Dermatitis. 2003 Aug;49(2):80-4. [Article]
DRUGS.COM [Link]
Webmd [Link]
Pubchem [Link]
ChemIDplus [Link]
BASG Product Information: Dolobene (DMSO/heparin sodium/dexpanthenol) topical gel [Link]

External Links

KEGG Drug: D00193
KEGG Compound: C05944
PubChem Compound: 131204
PubChem Substance: 347827835
ChemSpider: 115991
RxNav: 22701
ChEMBL: CHEMBL1200979
ZINC: ZINC000001530303
RxList: RxList Drug Page
Drugs.com: Drugs.com Drug Page
Wikipedia: Panthenol

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count
4	Completed	Basic Science	Cell Proliferation / Gene Expression / Promotion of wound healing	1
4	Completed	Treatment	Erythemas / Skin Recovery	1
4	Completed	Treatment	Promotion of wound healing	1
4	Completed	Treatment	Skin Recovery	2
4	Recruiting	Treatment	Acute Kidney Injury (AKI)	1
3	Completed	Supportive Care	Photodamaged Skin	1
3	Completed	Treatment	Appetite; Lack or Loss, Nonorganic Origin	1
3	Completed	Treatment	Breast Cancer	1
3	Completed	Treatment	HbA1c Level / Plasma Homocysteine	1
3	Completed	Treatment	Hydatidiform Moles	1

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Capsule; liquid	Oral
Syrup	Oral
Liquid	Topical
Solution	Intravenous	1.914 mg
Ointment	Topical	50 mg/1g
Solution
Solution		500 mg
Tablet, coated
Elixir	Oral
Powder, for solution	Intramuscular; Intravenous
Powder, for solution	Intravenous
Injection, solution		500 MG/2ML
Tablet		100 MG
Ointment
Ointment	Cutaneous	5 mg
Cream	Topical
Ointment	Topical
Lozenge		100 mg
Ointment	Nasal; Ophthalmic
Solution	Intramuscular; Intravenous; Subcutaneous	500 mg/2ml
Ointment	Nasal; Ophthalmic	50 mg/g
Solution	Oral	50 mg/g
Spray	Topical
Ointment		50 mg/g
Injection, powder, for solution	Intramuscular; Intravenous
Injection, powder, for solution	Parenteral
Injection, powder, for solution	Intravenous
Gel	Ophthalmic
Gel	Ophthalmic	50 mg/g
Gel	Ophthalmic	120 mg/0.6mL
Gel	Ophthalmic	30 mg/0.6mL
Gel	Ophthalmic	60 mg/0.6mL
Solution / drops; suspension / drops	Ophthalmic	50 mg/mL
Solution / drops; suspension / drops	Ophthalmic	30 mg/0.6mL
Solution / drops; suspension / drops	Ophthalmic	60 mg/0.6mL
Gel	Topical
Lozenge	Oral
Ointment	Topical	5 %
Injection, solution	Intramuscular; Intravenous	250 mg/1mL
Cream	Cutaneous
Cream	Topical	50 mg/g
Solution / drops; suspension / drops	Ophthalmic
Liquid	Oral
Gel	Topical	0.5 g/100mL
Liquid	Intramuscular; Intravenous
Ointment	Topical
Solution	Nasal
Injection	Intramuscular
Injection, solution, concentrate; kit	Intravenous
Injection, powder, lyophilized, for solution	Intravenous
Kit	Intravenous
Solution; spray	Nasal	50 mg/1mL
Spray	Nasal	10 mg/1ml
Solution	Intravenous
Liquid	Intravenous
Solution	Parenteral
Solution / drops	Oral
Spray	Nasal	50 mg/ml
Shampoo	Topical
Powder, for solution	Oral
Solution	Intramuscular; Intravenous
Solution	Buccal; Oropharyngeal
Gel	Buccal; Oral
Solution / drops; suspension / drops	Ophthalmic	50 mg
Injection, solution	Intramuscular; Intravenous	500 mg
Cream		5 %
Cream	Topical
Ointment		5 %
Solution	Oral	5 %
Ointment	Ophthalmic	5 g
Cream	Topical	100 g
Cream	Topical	20 g
Cream	Topical	50 g
Cream	Nasal	50 mg/g
Cream	Topical	5 G/100G
Cream	Topical	5 %
Injection, solution	Intramuscular; Intravenous; Subcutaneous	500 mg
Cream
Injection, solution; kit	Intravenous
Injection, solution	Intravenous
Solution	Oral
Patch	Topical
Liquid	Topical	0.001 g/1mL
Syrup
Solution / drops	Ophthalmic
Solution / drops	Ophthalmic
Liquid; tablet	Oral
Injection, powder, for solution	Intravenous	100 mg
Liquid	Topical	0.0005 g/1mL
Injection	Intramuscular; Intravenous
Injection	Intravenous
Injection, solution	Intramuscular; Intravenous
Spray	Nasal
Spray, metered	Nasal
Liquid	Topical	0.2 g/100g
Solution; spray	Nasal

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source
Water Solubility	121.0 mg/mL	ALOGPS
logP	-1	ALOGPS
logP	-1.7	Chemaxon
logS	-0.23	ALOGPS
pKa (Strongest Acidic)	12.69	Chemaxon
pKa (Strongest Basic)	-2.4	Chemaxon
Physiological Charge	0	Chemaxon
Hydrogen Acceptor Count	4	Chemaxon
Hydrogen Donor Count	4	Chemaxon
Polar Surface Area	89.79 Å²	Chemaxon
Rotatable Bond Count	6	Chemaxon
Refractivity	51.88 m³·mol^-1	Chemaxon
Polarizability	21.87 Å³	Chemaxon
Number of Rings	0	Chemaxon
Bioavailability	1	Chemaxon
Rule of Five	Yes	Chemaxon
Ghose Filter	No	Chemaxon
Veber's Rule	No	Chemaxon
MDDR-like Rule	No	Chemaxon

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST)

Not Available

Spectra

Spectrum	Spectrum Type	Splash Key
GC-MS Spectrum - GC-MS (4 TMS)	GC-MS	splash10-0f8a-1921000000-f1d6cd175435f0634e26
GC-MS Spectrum - GC-MS (3 TMS)	GC-MS	splash10-0ar9-0940000000-60184a3322815ca33b8c
Predicted GC-MS Spectrum - GC-MS	Predicted GC-MS	Not Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)	Predicted LC-MS/MS	Not Available

Drug created at November 30, 2015 19:10 / Updated at May 29, 2021 18:14

Dexpanthenol

Identification

Structure for Dexpanthenol (DB09357)

Pharmacology

Interactions

Products

Categories

Chemical Identifiers

References

Clinical Trials

Pharmacoeconomics

Properties

Spectra